Refine Your Results

Click below to filter your search results

"Cardiovascular Disease"Undo
"Guidelines - Gynecology"Undo
"Committee Opinion"Undo

Search Results

Return to List
Results 1–1 of 1
Sort By: Relevance| Date| Title

Committee Opinion Number 565, June 2013

(Replaces No. 420, November 2008, Reaffirmed 2015)

ABSTRACT: Menopausal hormone therapy should not be used for the primary or secondary prevention of coronary heart disease at the present time. Evidence is insufficient to conclude that long-term estrogen therapy or hormone therapy use improves cardiovascular outcomes. Nevertheless, recent evidence suggests that women in early menopause who are in good cardiovascular health are at low risk of adverse cardiovascular outcomes and should be considered candidates for the use of estrogen therapy or conjugated equine estrogen plus a progestin for relief of menopausal symptoms. There is some evidence...


American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998